{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T08:54:54Z","timestamp":1781513694171,"version":"3.54.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s00210-026-05150-x","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T02:21:34Z","timestamp":1772504494000},"page":"12037-12055","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The effects of low-dose X-ray pre-irradiation followed by 4-hydroxybenzoic acid and vanillic acid on P-glycoprotein-mediated efflux pirarubicin in multidrug-resistant K562\/Dox cells"],"prefix":"10.1007","volume":"399","author":[{"given":"Ohnmar","family":"Myint","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamaporn","family":"Supawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suchart","family":"Kothan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montree","family":"Tungjai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,3]]},"reference":[{"key":"5150_CR1","doi-asserted-by":"publisher","unstructured":"Afnan, Saleem A, Akhtar MF, Sharif A, Akhtar B, Siddique R, et al. Anticancer, cardio-protective and anti-inflammatory potential of natural-sources-derived phenolic acids. Molecules. 2022;27(21). https:\/\/doi.org\/10.3390\/molecules27217286.","DOI":"10.3390\/molecules27217286"},{"key":"5150_CR2","doi-asserted-by":"publisher","unstructured":"Almeida IV, Cavalcante FM, Vicentini VE (2016) Different responses of vanillic acid, a phenolic compound, in HTC cells: cytotoxicity, antiproliferative activity, and protection from DNA-induced damage. Genet Mol Res 15(4). https:\/\/doi.org\/10.4238\/gmr15049388.","DOI":"10.4238\/gmr15049388"},{"issue":"4","key":"5150_CR3","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/s0006-2952(02)01224-8","volume":"64","author":"S Anuchapreeda","year":"2002","unstructured":"Anuchapreeda S, Leechanachai P, Smith MM, Ambudkar SV, Limtrakul PN (2002) Modulation of P-glycoprotein expression and function by curcumin in multidrug-resistant human KB cells. Biochem Pharmacol 64(4):573\u2013582. https:\/\/doi.org\/10.1016\/s0006-2952(02)01224-8","journal-title":"Biochem Pharmacol"},{"issue":"9","key":"5150_CR4","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1002\/ptr.5873","volume":"31","author":"BL Athukuri","year":"2017","unstructured":"Athukuri BL, Neerati P (2017) Enhanced oral bioavailability of diltiazem by the influence of gallic acid and ellagic acid in male Wistar rats: involvement of CYP3A and P-gp inhibition. Phytother Res 31(9):1441\u20131448. https:\/\/doi.org\/10.1002\/ptr.5873","journal-title":"Phytother Res"},{"key":"5150_CR5","doi-asserted-by":"publisher","DOI":"10.3892\/or.2021.8178","author":"KT Aye","year":"2021","unstructured":"Aye KT, Wattanapongpitak S, Supawat B, Kothan S, Udomtanakunchai C, Tima S et al (2021) Gallic acid enhances pirarubicin\u2011induced anticancer in living K562 and K562\/Dox leukemia cancer cells through cellular energetic state impairment and P\u2011glycoprotein inhibition. Oncol Rep. https:\/\/doi.org\/10.3892\/or.2021.8178","journal-title":"Oncol Rep"},{"issue":"12","key":"5150_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-022-01835-4","volume":"39","author":"KT Aye","year":"2022","unstructured":"Aye KT, Wattanapongpitak S, Supawat B, Kothan S, Udomtanakunchai C, Tima S et al (2022) Effect of pre-low-dose irradiation on anticancer activities of gallic acid in leukemic K562 and K562\/Dox cells: cell viability and cellular energetic state studies. Med Oncol 39(12):229. https:\/\/doi.org\/10.1007\/s12032-022-01835-4","journal-title":"Med Oncol"},{"issue":"2","key":"5150_CR7","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1269\/jrr.45.239","volume":"45","author":"Z Chen","year":"2004","unstructured":"Chen Z, Sakai K (2004) Enhancement of radiation-induced apoptosis by preirradiation with low-dose X-rays in human leukemia MOLT-4 cells. J Radiat Res 45(2):239\u2013243. https:\/\/doi.org\/10.1269\/jrr.45.239","journal-title":"J Radiat Res"},{"issue":"11","key":"5150_CR8","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1271\/bbb.62.2273","volume":"62","author":"JY Cho","year":"1998","unstructured":"Cho JY, Moon JH, Seong KY, Park KH (1998) Antimicrobial activity of 4-hydroxybenzoic acid and trans 4-hydroxycinnamic acid isolated and identified from rice hull. Biosci Biotechnol Biochem 62(11):2273\u20132276. https:\/\/doi.org\/10.1271\/bbb.62.2273","journal-title":"Biosci Biotechnol Biochem"},{"issue":"4","key":"5150_CR9","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/s0006-291x(02)00755-6","volume":"295","author":"CH Choi","year":"2002","unstructured":"Choi CH, Sun KH, An CS, Yoo JC, Hahm KS, Lee IH et al (2002) Reversal of P-glycoprotein-mediated multidrug resistance by 5,6,7,3\u2019,4\u2019-pentamethoxyflavone (Sinensetin). Biochem Biophys Res Commun 295(4):832\u201340. https:\/\/doi.org\/10.1016\/s0006-291x(02)00755-6","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"5150_CR10","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s12272-011-0411-x","volume":"34","author":"JS Choi","year":"2011","unstructured":"Choi JS, Piao YJ, Kang KW (2011) Effects of quercetin on the bioavailability of doxorubicin in rats: role of CYP3A4 and P-gp inhibition by quercetin. Arch Pharm Res 34(4):607\u2013613. https:\/\/doi.org\/10.1007\/s12272-011-0411-x","journal-title":"Arch Pharm Res"},{"key":"5150_CR11","doi-asserted-by":"publisher","unstructured":"Choiprasert W, Dechsupa N, Kothan S, Garrigos M, Mankhetkorn S. Quercetin, Quercetrin except rutin potentially increased pirarubicin cytotoxicity by non-competitively inhibiting the P-Glycoprotein-and MRP1 function in living K562\/adr and GLC4\/adr cells. American Journal of Pharmacology and Toxicology. 2010;5(1). https:\/\/doi.org\/10.3844\/ajptsp.2010.24.33.","DOI":"10.3844\/ajptsp.2010.24.33"},{"issue":"7","key":"5150_CR12","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1007\/bf02977349","volume":"28","author":"SY Chung","year":"2005","unstructured":"Chung SY, Sung MK, Kim NH, Jang JO, Go EJ, Lee HJ (2005) Inhibition of P-glycoprotein by natural products in human breast cancer cells. Arch Pharm Res 28(7):823\u2013828. https:\/\/doi.org\/10.1007\/bf02977349","journal-title":"Arch Pharm Res"},{"issue":"20","key":"5150_CR13","doi-asserted-by":"publisher","first-page":"4077","DOI":"10.1182\/blood-2010-04-277269","volume":"116","author":"LD Cripe","year":"2010","unstructured":"Cripe LD, Uno H, Paietta EM, Litzow MR, Ketterling RP, Bennett JM et al (2010) Zosuquidar, a novel modulator of P-glycoprotein, does not improve the outcome of older patients with newly diagnosed acute myeloid leukemia: a randomized, placebo-controlled trial of the Eastern Cooperative Oncology Group 3999. Blood 116(20):4077\u201385. https:\/\/doi.org\/10.1182\/blood-2010-04-277269","journal-title":"Blood"},{"issue":"25","key":"5150_CR14","doi-asserted-by":"publisher","first-page":"4799","DOI":"10.2174\/0929867325666181001115225","volume":"26","author":"J Cui","year":"2019","unstructured":"Cui J, Liu X, Chow LMC (2019) Flavonoids as P-gp inhibitors: a systematic review of SARs. Curr Med Chem 26(25):4799\u20134831. https:\/\/doi.org\/10.2174\/0929867325666181001115225","journal-title":"Curr Med Chem"},{"issue":"4","key":"5150_CR15","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.tranon.2014.05.006","volume":"7","author":"KC Cuneo","year":"2014","unstructured":"Cuneo KC, Davis MA, Feng MU, Novelli PM, Ensminger WD, Lawrence TS (2014) Low dose rate radiosensitization of hepatocellular carcinoma in vitro and in patients. Transl Oncol 7(4):472\u2013478. https:\/\/doi.org\/10.1016\/j.tranon.2014.05.006","journal-title":"Transl Oncol"},{"issue":"18","key":"5150_CR16","first-page":"4171","volume":"56","author":"AH Dantzig","year":"1996","unstructured":"Dantzig AH, Shepard RL, Cao J, Law KL, Ehlhardt WJ, Baughman TM et al (1996) Reversal of P-glycoprotein-mediated multidrug resistance by a potent cyclopropyldibenzosuberane modulator, LY335979. Cancer Res 56(18):4171\u20134179","journal-title":"Cancer Res"},{"issue":"2","key":"5150_CR17","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/S0022-3565(24)34974-2","volume":"290","author":"AH Dantzig","year":"1999","unstructured":"Dantzig AH, Shepard RL, Law KL, Tabas L, Pratt S, Gillespie JS et al (1999) Selectivity of the multidrug resistance modulator, LY335979, for P-glycoprotein and effect on cytochrome P-450 activities. J Pharmacol Exp Ther 290(2):854\u2013862","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"5150_CR18","doi-asserted-by":"publisher","first-page":"39","DOI":"10.2174\/0929867013373903","volume":"8","author":"AH Dantzig","year":"2001","unstructured":"Dantzig AH, Law KL, Cao J, Starling JJ (2001) Reversal of multidrug resistance by the P-glycoprotein modulator, LY335979, from the bench to the clinic. Curr Med Chem 8(1):39\u201350. https:\/\/doi.org\/10.2174\/0929867013373903","journal-title":"Curr Med Chem"},{"issue":"3","key":"5150_CR19","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1111\/j.1432-1033.1995.tb20352.x","volume":"228","author":"S Drori","year":"1995","unstructured":"Drori S, Eytan GD, Assaraf YG (1995) Potentiation of anticancer-drug cytotoxicity by multidrug-resistance chemosensitizers involves alterations in membrane fluidity leading to increased membrane permeability. Eur J Biochem 228(3):1020\u20131029. https:\/\/doi.org\/10.1111\/j.1432-1033.1995.tb20352.x","journal-title":"Eur J Biochem"},{"issue":"1","key":"5150_CR20","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/j.1432-1033.1997.00104.x","volume":"248","author":"GD Eytan","year":"1997","unstructured":"Eytan GD, Regev R, Oren G, Hurwitz CD, Assaraf YG (1997) Efficiency of P-glycoprotein-mediated exclusion of rhodamine dyes from multidrug-resistant cells is determined by their passive transmembrane movement rate. Eur J Biochem 248(1):104\u2013112. https:\/\/doi.org\/10.1111\/j.1432-1033.1997.00104.x","journal-title":"Eur J Biochem"},{"key":"5150_CR21","doi-asserted-by":"publisher","DOI":"10.1590\/S1677-04202006000100003","author":"A Farah","year":"2006","unstructured":"Farah A, Donangelo C (2006) Phenolic compounds in coffee. Braz J Plant Physiol. https:\/\/doi.org\/10.1590\/S1677-04202006000100003","journal-title":"Braz J Plant Physiol"},{"key":"5150_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20030465","author":"J Gong","year":"2019","unstructured":"Gong J, Zhou S, Yang S (2019) Vanillic acid suppresses HIF-1\u03b1 expression via inhibition of mTOR\/p70S6K\/4E-BP1 and Raf\/MEK\/ERK pathways in human colon cancer HCT116 cells. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms20030465","journal-title":"Int J Mol Sci"},{"issue":"2","key":"5150_CR23","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/s0014-5793(97)00940-x","volume":"413","author":"JH Hooijberg","year":"1997","unstructured":"Hooijberg JH, Broxterman HJ, Heijn M, Fles DL, Lankelma J, Pinedo HM (1997) Modulation by (iso)flavonoids of the ATPase activity of the multidrug resistance protein. FEBS Lett 413(2):344\u2013348. https:\/\/doi.org\/10.1016\/s0014-5793(97)00940-x","journal-title":"FEBS Lett"},{"issue":"7","key":"5150_CR24","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1248\/bpb.32.1215","volume":"32","author":"A Itoh","year":"2009","unstructured":"Itoh A, Isoda K, Kondoh M, Kawase M, Kobayashi M, Tamesada M et al (2009) Hepatoprotective effect of syringic acid and vanillic acid on concanavalin a-induced liver injury. Biol Pharm Bull 32(7):1215\u20139. https:\/\/doi.org\/10.1248\/bpb.32.1215","journal-title":"Biol Pharm Bull"},{"issue":"4","key":"5150_CR25","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1667\/rr1132.1","volume":"170","author":"H Jiang","year":"2008","unstructured":"Jiang H, Xu Y, Li W, Ma K, Cai L, Wang G (2008) Low-dose radiation does not induce proliferation in tumor cells in vitro and in vivo. Radiat Res 170(4):477\u2013487. https:\/\/doi.org\/10.1667\/rr1132.1","journal-title":"Radiat Res"},{"issue":"10","key":"5150_CR26","first-page":"4413","volume":"32","author":"TY Kao","year":"2012","unstructured":"Kao TY, Chung YC, Hou YC, Tsai YW, Chen CH, Chang HP et al (2012) Effects of ellagic acid on chemosensitivity to 5-fluorouracil in colorectal carcinoma cells. Anticancer Res 32(10):4413\u20134418","journal-title":"Anticancer Res"},{"issue":"11","key":"5150_CR27","doi-asserted-by":"publisher","first-page":"7985","DOI":"10.3390\/molecules15117985","volume":"15","author":"S Khadem","year":"2010","unstructured":"Khadem S, Marles RJ (2010) Monocyclic phenolic acids; hydroxy- and polyhydroxybenzoic acids: occurrence and recent bioactivity studies. Molecules 15(11):7985\u20138005. https:\/\/doi.org\/10.3390\/molecules15117985","journal-title":"Molecules"},{"key":"5150_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-020-1100-y","volume":"20","author":"K Khorsandi","year":"2020","unstructured":"Khorsandi K, Kianmehr Z, Hosseinmardi Z, Hosseinzadeh R (2020) Anti-cancer effect of gallic acid in presence of low level laser irradiation: ROS production and induction of apoptosis and ferroptosis. Cancer Cell Int 20:18. https:\/\/doi.org\/10.1186\/s12935-020-1100-y","journal-title":"Cancer Cell Int"},{"issue":"2","key":"5150_CR29","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1097\/cmr.0000000000000603","volume":"30","author":"Z Kianmehr","year":"2020","unstructured":"Kianmehr Z, Khorsandi K, Mohammadi M, Hosseinzadeh R (2020) Low-level laser irradiation potentiates anticancer activity of p-coumaric acid against human malignant melanoma cells. Melanoma Res 30(2):136\u2013146. https:\/\/doi.org\/10.1097\/cmr.0000000000000603","journal-title":"Melanoma Res"},{"issue":"10","key":"5150_CR30","doi-asserted-by":"publisher","first-page":"7208","DOI":"10.3390\/molecules15107208","volume":"15","author":"SJ Kim","year":"2010","unstructured":"Kim SJ, Kim MC, Um JY, Hong SH (2010) The beneficial effect of vanillic acid on ulcerative colitis. Molecules 15(10):7208\u20137217. https:\/\/doi.org\/10.3390\/molecules15107208","journal-title":"Molecules"},{"issue":"6","key":"5150_CR31","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1080\/13543776.2019.1618273","volume":"29","author":"M Leopoldo","year":"2019","unstructured":"Leopoldo M, Nardulli P, Contino M, Leonetti F, Luurtsema G, Colabufo NA (2019) An updated patent review on P-glycoprotein inhibitors (2011-2018). Expert Opin Ther Pat 29(6):455\u2013461. https:\/\/doi.org\/10.1080\/13543776.2019.1618273","journal-title":"Expert Opin Ther Pat"},{"issue":"1","key":"5150_CR32","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.tiv.2008.09.015","volume":"23","author":"X Li","year":"2009","unstructured":"Li X, Sun B, Zhu CJ, Yuan HQ, Shi YQ, Gao J et al (2009) Reversal of p-glycoprotein-mediated multidrug resistance by macrocyclic bisbibenzyl derivatives in adriamycin-resistant human myelogenous leukemia (K562\/A02) cells. Toxicol In Vitro 23(1):29\u201336. https:\/\/doi.org\/10.1016\/j.tiv.2008.09.015","journal-title":"Toxicol In Vitro"},{"issue":"4","key":"5150_CR33","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.bbrc.2020.01.048","volume":"523","author":"Y Li","year":"2020","unstructured":"Li Y, Wang Z, Jin J, Zhu SX, He GQ, Li SH et al (2020) Quercetin pretreatment enhances the radiosensitivity of colon cancer cells by targeting Notch-1 pathway. Biochem Biophys Res Commun 523(4):947\u201353. https:\/\/doi.org\/10.1016\/j.bbrc.2020.01.048","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"5150_CR34","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1097\/00004032-198212000-00001","volume":"43","author":"TD Luckey","year":"1982","unstructured":"Luckey TD (1982) Physiological benefits from low levels of ionizing radiation. Health Phys 43(6):771\u2013789. https:\/\/doi.org\/10.1097\/00004032-198212000-00001","journal-title":"Health Phys"},{"issue":"2","key":"5150_CR35","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/sj.bjp.0702807","volume":"128","author":"C Martin","year":"1999","unstructured":"Martin C, Berridge G, Mistry P, Higgins C, Charlton P, Callaghan R (1999) The molecular interaction of the high affinity reversal agent XR9576 with P-glycoprotein. Br J Pharmacol 128(2):403\u2013411. https:\/\/doi.org\/10.1038\/sj.bjp.0702807","journal-title":"Br J Pharmacol"},{"key":"5150_CR36","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.ejphar.2016.05.023","volume":"786","author":"G Muthusamy","year":"2016","unstructured":"Muthusamy G, Balupillai A, Ramasamy K, Shanmugam M, Gunaseelan S, Mary B et al (2016) Ferulic acid reverses ABCB1-mediated paclitaxel resistance in MDR cell lines. Eur J Pharmacol 786:194\u2013203. https:\/\/doi.org\/10.1016\/j.ejphar.2016.05.023","journal-title":"Eur J Pharmacol"},{"key":"5150_CR37","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jnutbio.2018.09.022","volume":"63","author":"G Muthusamy","year":"2019","unstructured":"Muthusamy G, Gunaseelan S, Prasad NR (2019) Ferulic acid reverses P-glycoprotein-mediated multidrug resistance via inhibition of PI3K\/Akt\/NF-\u03baB signaling pathway. J Nutr Biochem 63:62\u201371. https:\/\/doi.org\/10.1016\/j.jnutbio.2018.09.022","journal-title":"J Nutr Biochem"},{"key":"5150_CR38","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1016\/j.toxrep.2021.07.001","volume":"8","author":"O Myint","year":"2021","unstructured":"Myint O, Wattanapongpitak S, Supawat B, Kothan S, Udomtanakunchai C, Tima S et al (2021) Protein binding of 4-hydroxybenzoic acid and 4-hydroxy-3-methoxybenzoic acid to human serum albumin and their anti-proliferation on doxorubicin-sensitive and doxorubicin-resistant leukemia cells. Toxicol Rep 8:1381\u20138. https:\/\/doi.org\/10.1016\/j.toxrep.2021.07.001","journal-title":"Toxicol Rep"},{"key":"5150_CR39","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1016\/j.toxrep.2022.06.017","volume":"9","author":"O Myint","year":"2022","unstructured":"Myint O, Wattanapongpitak S, Kothan S, Udomtanakunchai C, Tima S, Tungjai M (2022) Modulation of p-glycoprotein-mediated efflux pirarubicin in living multidrug-resistant K562\/Dox cell lines by 4-hydroxybenzoic acid and 4-hydroxy-3-methoxybenzoic acid via impairment of the cellular energetic state. Toxicol Rep 9:1443\u20131451. https:\/\/doi.org\/10.1016\/j.toxrep.2022.06.017","journal-title":"Toxicol Rep"},{"issue":"2-3","key":"5150_CR40","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.ejps.2005.03.001","volume":"25","author":"M Ofer","year":"2005","unstructured":"Ofer M, Wolffram S, Koggel A, Spahn-Langguth H, Langguth P (2005) Modulation of drug transport by selected flavonoids: involvement of P-gp and OCT? Eur J Pharm Sci 25(2\u20133):263\u201371. https:\/\/doi.org\/10.1016\/j.ejps.2005.03.001","journal-title":"Eur J Pharm Sci"},{"issue":"13","key":"5150_CR41","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.2174\/092986712800167392","volume":"19","author":"A Palmeira","year":"2012","unstructured":"Palmeira A, Sousa E, Vasconcelos MH, Pinto MM (2012) Three decades of P-gp inhibitors: skimming through several generations and scaffolds. Curr Med Chem 19(13):1946\u20132025. https:\/\/doi.org\/10.2174\/092986712800167392","journal-title":"Curr Med Chem"},{"issue":"1-2","key":"5150_CR42","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1046\/j.1432-1327.1999.00037.x","volume":"259","author":"R Regev","year":"1999","unstructured":"Regev R, Assaraf YG, Eytan GD (1999) Membrane fluidization by ether, other anesthetics, and certain agents abolishes P-glycoprotein ATPase activity and modulates efflux from multidrug-resistant cells. Eur J Biochem 259(1\u20132):18\u201324. https:\/\/doi.org\/10.1046\/j.1432-1327.1999.00037.x","journal-title":"Eur J Biochem"},{"issue":"12","key":"5150_CR43","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1248\/bpb.25.1555","volume":"25","author":"P Reungpatthanaphong","year":"2002","unstructured":"Reungpatthanaphong P, Mankhetkorn S (2002) Modulation of multidrug resistance by artemisinin, artesunate and dihydroartemisinin in K562\/adr and GLC4\/adr resistant cell lines. Biol Pharm Bull 25(12):1555\u20131561. https:\/\/doi.org\/10.1248\/bpb.25.1555","journal-title":"Biol Pharm Bull"},{"issue":"4","key":"5150_CR44","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/s0006-2952(96)00826-x","volume":"53","author":"AB Shapiro","year":"1997","unstructured":"Shapiro AB, Ling V (1997) Effect of quercetin on Hoechst 33342 transport by purified and reconstituted P-glycoprotein. Biochem Pharmacol 53(4):587\u2013596. https:\/\/doi.org\/10.1016\/s0006-2952(96)00826-x","journal-title":"Biochem Pharmacol"},{"key":"5150_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.00041","volume":"8","author":"J Sia","year":"2020","unstructured":"Sia J, Szmyd R, Hau E, Gee HE (2020) Molecular mechanisms of radiation-induced cancer cell death: a primer. Front Cell Dev Biol 8:41. https:\/\/doi.org\/10.3389\/fcell.2020.00041","journal-title":"Front Cell Dev Biol"},{"issue":"2","key":"5150_CR46","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s12013-019-00868-3","volume":"77","author":"B Supawat","year":"2019","unstructured":"Supawat B, Udomtanakunchai C, Kothan S, Tungjai M (2019) The effects of iodinated radiographic contrast media on multidrug-resistant K562\/Dox cells: mitochondria impairment and P-glycoprotein inhibition. Cell Biochem Biophys 77(2):157\u2013163. https:\/\/doi.org\/10.1007\/s12013-019-00868-3","journal-title":"Cell Biochem Biophys"},{"key":"5150_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtemb.2020.126640","volume":"62","author":"B Supawat","year":"2020","unstructured":"Supawat B, Moungthong P, Chanloi C, Jindachai N, Tima S, Kothan S et al (2020) Effects of gadolinium-based magnetic resonance imaging contrast media on red blood cells and K562 cancer cells. J Trace Elem Med Biol 62:126640. https:\/\/doi.org\/10.1016\/j.jtemb.2020.126640","journal-title":"J Trace Elem Med Biol"},{"issue":"9-10","key":"5150_CR48","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.drudis.2007.12.010","volume":"13","author":"G Szak\u00e1cs","year":"2008","unstructured":"Szak\u00e1cs G, V\u00e1radi A, Ozvegy-Laczka C, Sarkadi B (2008) The role of ABC transporters in drug absorption, distribution, metabolism, excretion and toxicity (ADME-Tox). Drug Discov Today 13(9\u201310):379\u2013393. https:\/\/doi.org\/10.1016\/j.drudis.2007.12.010","journal-title":"Drug Discov Today"},{"key":"5150_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25020247","author":"YN Teng","year":"2020","unstructured":"Teng YN, Wang CCN, Liao WC, Lan YH, Hung CC (2020) Caffeic acid attenuates multi-drug resistance in cancer cells by inhibiting efflux function of human P-glycoprotein. Molecules. https:\/\/doi.org\/10.3390\/molecules25020247","journal-title":"Molecules"},{"issue":"5","key":"5150_CR50","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1097\/hp.0000000000000647","volume":"112","author":"M Tungjai","year":"2017","unstructured":"Tungjai M, Phathakanon N, Rithidech KN (2017) Effects of medical diagnostic low-dose X rays on human lymphocytes: mitochondrial membrane potential, apoptosis and cell cycle. Health Phys 112(5):458\u2013464. https:\/\/doi.org\/10.1097\/hp.0000000000000647","journal-title":"Health Phys"},{"issue":"4","key":"5150_CR51","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/s1043-6618(03)00158-0","volume":"48","author":"MV Varma","year":"2003","unstructured":"Varma MV, Ashokraj Y, Dey CS, Panchagnula R (2003) P-glycoprotein inhibitors and their screening: a perspective from bioavailability enhancement. Pharmacol Res 48(4):347\u2013359. https:\/\/doi.org\/10.1016\/s1043-6618(03)00158-0","journal-title":"Pharmacol Res"},{"key":"5150_CR52","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.biopha.2016.12.134","volume":"87","author":"K Vinothiya","year":"2017","unstructured":"Vinothiya K, Ashokkumar N (2017) Modulatory effect of vanillic acid on antioxidant status in high fat diet-induced changes in diabetic hypertensive rats. Biomed Pharmacother 87:640\u2013652. https:\/\/doi.org\/10.1016\/j.biopha.2016.12.134","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"5150_CR53","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s12192-017-0834-5","volume":"23","author":"KV Vishnu","year":"2018","unstructured":"Vishnu KV, Ajeesh Kumar KK, Chatterjee NS, Lekshmi RGK, Sreerekha PR, Mathew S et al (2018) Sardine oil loaded vanillic acid grafted chitosan microparticles, a new functional food ingredient: attenuates myocardial oxidative stress and apoptosis in cardiomyoblast cell lines (H9c2). Cell Stress Chaperones 23(2):213\u201322. https:\/\/doi.org\/10.1007\/s12192-017-0834-5","journal-title":"Cell Stress Chaperones"},{"issue":"4","key":"5150_CR54","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.bbrc.2018.08.043","volume":"504","author":"XN Wang","year":"2018","unstructured":"Wang XN, Wang KY, Zhang XS, Yang C, Li XY (2018) 4-hydroxybenzoic acid (4-HBA) enhances the sensitivity of human breast cancer cells to adriamycin as a specific HDAC6 inhibitor by promoting HIPK2\/p53 pathway. Biochem Biophys Res Commun 504(4):812\u2013819. https:\/\/doi.org\/10.1016\/j.bbrc.2018.08.043","journal-title":"Biochem Biophys Res Commun"},{"key":"5150_CR55","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/6297080","volume":"2017","author":"AN Winter","year":"2017","unstructured":"Winter AN, Brenner MC, Punessen N, Snodgrass M, Byars C, Arora Y et al (2017) Comparison of the neuroprotective and anti-inflammatory effects of the anthocyanin metabolites, protocatechuic acid and 4-hydroxybenzoic acid. Oxid Med Cell Longev 2017:6297080. https:\/\/doi.org\/10.1155\/2017\/6297080","journal-title":"Oxid Med Cell Longev"},{"key":"5150_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.153998","volume":"99","author":"P Xue","year":"2022","unstructured":"Xue P, Zhang G, Zhang J, Ren L (2022) Synergism of ellagic acid in combination with radiotherapy and chemotherapy for cancer treatment. Phytomedicine 99:153998. https:\/\/doi.org\/10.1016\/j.phymed.2022.153998","journal-title":"Phytomedicine"},{"issue":"10","key":"5150_CR57","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1002\/ijc.30235","volume":"139","author":"G Yang","year":"2016","unstructured":"Yang G, Li W, Jiang H, Liang X, Zhao Y, Yu D et al (2016) Low-dose radiation may be a novel approach to enhance the effectiveness of cancer therapeutics. Int J Cancer 139(10):2157\u201368. https:\/\/doi.org\/10.1002\/ijc.30235","journal-title":"Int J Cancer"},{"issue":"7","key":"5150_CR58","first-page":"1036","volume":"117","author":"HS Yu","year":"2004","unstructured":"Yu HS, Song AQ, Lu YD, Qiu WS, Shen FZ (2004) Effects of low-dose radiation on tumor growth, erythrocyte immune function and SOD activity in tumor-bearing mice. Chin Med J (Engl) 117(7):1036\u20131039","journal-title":"Chin Med J (Engl)"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05150-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05150-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05150-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T08:18:47Z","timestamp":1781511527000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05150-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,3]]},"references-count":58,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["5150"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05150-x","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,3]]},"assertion":[{"value":"29 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}]}}